Ken Griffin Scholar Rock Holding Corp Transaction History

Citadel Advisors LLC

$559 Billion
Q4 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 99,300 shares of SRRK stock, worth $3.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,300

Previous 31,500 215.24%

Holding current value

$3.66 Million

Previous $252,000 1602.78%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$7.07 - $45.73 $6.61 Million - $42.7 Million	934,585 Added 119.29%	1,718,059 $74.3 Million
Q3 2024 Nov 14, 2024	BUY	$7.63 - $9.71 $5.12 Million - $6.51 Million	670,478 Added 593.36%	783,474 $6.28 Million
Q2 2024 Aug 14, 2024	SELL	$7.84 - $16.79 $4.17 Million - $8.93 Million	-531,793 Reduced 82.48%	112,996 $941,000
Q1 2024 May 15, 2024	BUY	$13.2 - $17.76 $1.4 Million - $1.88 Million	105,939 Added 19.66%	644,789 $11.5 Million
Q4 2023 Feb 14, 2024	BUY	$6.52 - $20.32 $3.22 Million - $10 Million	493,130 Added 1078.59%	538,850 $10.1 Million
Q3 2023 Nov 14, 2023	BUY	$6.02 - $7.76 $275,234 - $354,787	45,720 New	45,720 $324,000
Q1 2023 May 15, 2023	SELL	$7.36 - $12.72 $59,093 - $102,128	-8,029 Reduced 6.91%	108,134 $865,000
Q4 2022 Feb 14, 2023	SELL	$7.02 - $9.76 $1.31 Million - $1.82 Million	-186,963 Reduced 61.68%	116,163 $1.05 Million
Q3 2022 Nov 14, 2022	BUY	$5.33 - $11.3 $443,770 - $940,826	83,259 Added 37.87%	303,126 $2.1 Million
Q2 2022 Aug 15, 2022	SELL	$4.66 - $13.96 $17,922 - $53,690	-3,846 Reduced 1.72%	219,867 $1.21 Million
Q1 2022 May 16, 2022	BUY	$11.89 - $24.68 $1.69 Million - $3.51 Million	142,143 Added 174.26%	223,713 $2.88 Million
Q3 2021 Nov 15, 2021	SELL	$27.38 - $42.21 $1.89 Million - $2.91 Million	-69,011 Reduced 45.83%	81,570 $2.69 Million
Q2 2021 Aug 16, 2021	BUY	$26.34 - $46.62 $2.68 Million - $4.74 Million	101,706 Added 208.09%	150,581 $4.35 Million
Q1 2021 May 17, 2021	SELL	$45.96 - $68.02 $4.07 Million - $6.03 Million	-88,591 Reduced 64.45%	48,875 $2.48 Million
Q4 2020 Feb 16, 2021	BUY	$13.72 - $51.57 $738,945 - $2.78 Million	53,859 Added 64.42%	137,466 $6.67 Million
Q3 2020 Nov 16, 2020	BUY	$10.54 - $18.47 $393,542 - $689,632	37,338 Added 80.7%	83,607 $1.48 Million
Q2 2020 Aug 14, 2020	BUY	$10.37 - $20.64 $315,559 - $628,075	30,430 Added 192.12%	46,269 $842,000
Q1 2020 May 15, 2020	SELL	$9.63 - $17.14 $180,745 - $321,700	-18,769 Reduced 54.23%	15,839 $192,000
Q4 2019 Feb 14, 2020	BUY	$7.2 - $13.2 $11,973 - $21,951	1,663 Added 5.05%	34,608 $456,000
Q3 2019 Nov 14, 2019	BUY	$8.95 - $15.72 $80,639 - $141,637	9,010 Added 37.64%	32,945 $294,000
Q2 2019 Aug 14, 2019	BUY	$14.61 - $22.45 $349,690 - $537,340	23,935 New	23,935 $380,000

Others Institutions Holding SRRK

# of Institutions

257

Shares Held

88.6M

Call Options Held

1.82M

Put Options Held

1.17M

View Full List

About Scholar Rock Holding Corp

Ticker SRRK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,640,600
Market Cap $1.9B
Description
Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...

More about SRRK

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account